Noladin ether, a putative endocannabinoid, attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed via a non-CB 1/CB 2 G i/o linked receptor

British Journal of Pharmacology

Volumn 142, Issue 3, 2004, Pages 509-518

  Duncan, Marnie ^a   Millns, Paul ^a   Smart, Darren ^b   Wright, James E ^b   Kendall, David A ^a   Ralevic, Vera ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cannabinoids; Rat mesenteric bed; Sensory neurotransmission

Indexed keywords

4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; ANANDAMIDE; CALCITONIN GENE RELATED PEPTIDE; CALCIUM ION; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR ANTAGONIST; CAPSAICIN; ETHER DERIVATIVE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN COUPLED RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN COUPLED RECEPTOR; NOLADIN ETHER; PERTUSSIS TOXIN; RIMONABANT; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; ELECTRIC FIELD; ELECTROSTIMULATION; EMBRYO; HUMAN; HUMAN CELL; MALE; MESENTERY BLOOD FLOW; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE; SPINAL GANGLION; VASODILATATION;

ANIMALS; CALCIUM; CELL LINE; CLONING, MOLECULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENDOCANNABINOIDS; GANGLIA, SPINAL; GLYCERIDES; HUMANS; MALE; MESENTERIC ARTERY, SUPERIOR; RATS; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RECEPTORS, DRUG; SYNAPTIC TRANSMISSION; VASODILATION;

EID: 3042703077     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705789     Document Type: Article

References (38)

1. AHLUWALIA, J., URBAN, L., CAPOGNA, M., BEVAN, S. & NAGY, I. (2000). Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience, 100, 685-688.
2. BREIVOGEL, C.S., GRIFFIN, G., DI MARZO, V. & MARTIN, B.R. (2001). Evidence for a new G protein coupled cannabinoid receptor in the mouse brain. Mol. Pharmacol., 60, 155-163.
3. BUNDEY, R.A. & KENDALL, D.A. (1999). Inhibition of receptor-mediated calcium responses by corticotrophin-releasing hormone in the CATH.a cell line. Neuropharmacology, 38, 39-47.
4. 2 receptor-mediated actions of anandamide in the mouse brain. J. Neurochem., 75, 2434-2444.
5. DI MARZO, V., DE PETROCELLIS, L., FEZZA, F., LIGRESTI, A. & BISOGNO, T. (2002). Anandamide receptors. Prostaglandins Leukotrienes Essential fatty acids, 66, 377-391.
6. DUNCAN, M., KENDALL, D.A. & RALEVIC, V. (2001a). Effect of WIN55,212, a cannabinoid receptor agonist, on sensory neurotransmission in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 135, 65P.
7. DUNCAN, M., KENDALL, D.A. & RALEVIC, V. (2001b). CP55,940, a cannabinoid receptor agonist, attenuates sensory neurotransmission via CB1-like receptors in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 135, 285P.
8. DUNCAN, M., KENDALL, D.A. & RALEVIC, V. (2002). The endocannabinoid noladin ether attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 136, 13P.
9. 9- Tetrahydrocannabinol attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed. Br. J. Pharmacol., 138, 214p.
10. DUNCAN, M., KENDALL, D.A. & RALEVIC, V. (2003b). The effects of ruthenium red on the inhibitory actions of noladin ether, THC & HU210 on sensory neurotransmission in the rat isolated mesenteric arterial bed. First European Workshop on Cannabinoid Research. http://www.ucm.es/info/seic-web/ abstract-book.pdf.
11. i/o linked cannabinoid receptor. 13th Symposium on Cannabinoids, International Cannabinoid Research Society http://www.cannabinoidsociety.org.
12. FEZZA, F., BISOGNO, T., MINASSI, A., APPENDINO, G., MECHOULAM, R. & DI MARZO, V. (2002). Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett., 513, 294-298.
13. HÁJOS, N., LEDENT, C. & FREUND, T.F. (2001). Novel cannabinoid-sensitive receptor mediates inhibition of glutamateric synaptic transmission in the hippocampus. Neuroscience, 106, 1-4.
14. HANUŠ, L., SALEH, A., FRIDE, E., BREUER, A., VOGEL, Z., SHALEV, D.E., KUSTANOVICH, I. & MECHOULAM, R. (2001). 2-Arachidonyl glyceryl ether, an endogenous agonist at the cannabinoid receptor. Proc Natl Acad Sci U.S.A., 98, 3662-3665.
15. HAYES, P., MEADOWS, H.J., GUNTHORPE, M.J., HARRIES, M.H., DUCKWORTH, M.D., CAIRNS, W., HARRISON, D.C., CLARKE, C.E., ELLINGTON, K., PRINJHA, R.K., BARTON, A.J.L., MEDHURST, A.D., SMITH, G.D., TOPP, S., MURDOCK, P., SANGER, G.J., TERRETT, J., JENKINS, O., BENHAM, C.D., RANDALL, A.D., GLOGER, I.S. & DAVIS, J.B. (2000). Cloning and functional expression of a human orthologue of rat vanilloid receptor-1. Pain, 88, 207-212.
16. HOHMANN, A.G. & HERKENHAM, M. (1999). Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience, 92, 1171-1175.
17. 2 receptors. Proc. Natl. Acad. Sci. U.S.A., 96, 14136-14141.
18. LINDSAY, R.M. (1988). Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons. J. Neurosci., 8, 2394-2405.
19. MECHOULAM, R., FRIDE, E., BEN-SHABAT, S., MEIRI, U. & HOROWITZ, M. (1998). Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid. Eur. J. Pharmacol., 362, R1-R3.
20. MILLNS, P., CHAPMAN, V. & KENDALL, D.A. (2001). Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones. Br. J. Pharmacol., 132, 969-971.
21. 2+]; responses in adult dorsal root ganglion neurones. Br. J. Pharmacol., 135, 256P.
22. OFFERTALER, L., MO, F.M., BATKAI, S., LIU, J., BEGG, M., RAZDAN, R.K., MARTIN, B.R., BUKOSKI, R.D. & KUNOS, G. (2003). Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor. Mol. Pharmacol., 63, 699-705.
23. OKA, S., TSUCHIE, A., TOKUMURA, A., MURAMASTU, M., SUHARA, Y., TAKAYAMA, H., WAKU, K. & SUGIURA, T. (2003). Ether-linked analogue of 2-arachidonylglycerol (noladin ether) was not detected in the brains of various mammalian species. J. Neurochem., 85, 1374-1381.
24. PERTWEE, R.G. (1999). Pharmacology of cannabinoid receptor ligands. Curr. Med. Chem., 6, 635-664.
25. RALEVIC, V. (2003). Cannabinoid modulation of peripheral autonomic and sensory neurotransmission. Eur. J. Pharmacol., 472, 1-21.
26. RALEVIC, V., ABERDEEN, J.A. & BURNSTOCK, G. (1991). Acrylamide-induced autonomic neuropathy of rat mesenteric vessels: histological and pharmacological studies. J. Auton. Nerv. Syst., 34, 77-88.
27. RALEVIC, V. & KENDALL, D.A. (2001). Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed. Eur. J. Pharmacol., 418, 117-125.
28. 1 subtype. J. Pharmacol. Exp. Ther., 267, 1100-1104.
29. 1 receptor-dependant G-protein activation in rat cerebellar membranes. Br. J. Pharmacol., 134, 664-672.
30. SCHULTZ, J.O.E.L.J., HSU, A.K., BARBIERI, J.T., LI, P. & GROSS, G.J. (1998). Pertussis toxin abolishes the cardioprotective effect of ischemic preconditioning in intact rat heart. Am. J. Physiol., 275, H495-H500.
31. SMART, D., GUNTHORPE, M.J., JERMAN, J.C., NASIR, S., GRAY, J., MUIR, A.I., CHAMBERS, J.K., RANDALL, A.D. & DAVIS, J.B. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br. J. Pharmacol., 129, 227-230.
32. SMART, D., JERMAN, J.C., GUNTHORPE, M.J., BROUGH, S.J., RANSON, J., CAIRNS, W., HAYES, P.D., RANDALL, A.D. & DAVIS, J.B. (2001). Characterisation using FLIPR of human vanilloid receptor (VR1) pharmacology. Eur. J. Pharmacol., 417, 51-58.
33. SUGIURA, T., KODAKA, T., NAKANE, S., MIYASHITA, T., KONDO, S., SUHARA, Y., TAKAYAMA, H., WAKU, K., SEKI, C., BABA, N. & ISHIMA, Y. (1999). Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem., 274, 2794-2801.
34. SZALLASI, A. & BLUMBERG, P.M. (1999). Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev., 51, 159-212.
35. WAGNER, J.A., VARGA, K., JARAI, Z. & KUNOS, G. (1999). Mesenteric vasodilation mediated by endothelial anandamide receptors. Hypertension, 33, 429-434.
36. WOOD, M.D. & SMART, D. (2001). Real time receptor function in vitro: microphysiometry and FLIPR. In: Receptors: A Practical Approach, ed. Stanford, C.S. & Horton, R.W. pp. 175-191. Oxford University Press: Oxford.
37. 2 cannabinoid receptor-independent mechanism. J. Neurosci., 22, 4720-4727.
38. ZYGMUNT, P.M., PETERSSON, J., ANDERSSON, D.A., CHUANG, H., SØRGARD, M., DI MARZO, V., JULIUS, D. & HÖGESTÄTT, E.D. (1999). Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature, 400, 452-456.